Edition:
United States

Pacific Biosciences of California Inc (PACB.OQ)

PACB.OQ on NASDAQ Stock Exchange Global Select Market

2.57USD
16 Feb 2018
Change (% chg)

$0.03 (+1.18%)
Prev Close
$2.54
Open
$2.53
Day's High
$2.64
Day's Low
$2.53
Volume
210,430
Avg. Vol
233,884
52-wk High
$5.73
52-wk Low
$2.22

Latest Key Developments (Source: Significant Developments)

Pacific Biosciences Of California Prices Public Offering
Tuesday, 13 Feb 2018 09:00am EST 

Feb 13 (Reuters) - Pacific Biosciences Of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 12.5 MILLION COMMON SHARES PRICED AT $2.40PER SHARE.  Full Article

Pacific Biosciences Of California Announces Proposed Public Offering Of Common Stock
Monday, 12 Feb 2018 04:01pm EST 

Feb 12 (Reuters) - Pacific Biosciences Of California Inc ::PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.PACIFIC BIOSCIENCES OF CALIFORNIA INC - MAY USE PORTION OF NET PROCEEDS FROM OFFERING TO ACQUIRE OR INVEST IN COMPLEMENTARY BUSINESSES, OTHERS.  Full Article

Pacific Biosciences Announces Qtrly Diluted Net Loss Per Share $0.18
Thursday, 1 Feb 2018 04:00pm EST 

Feb 1 (Reuters) - Pacific Biosciences Of California Inc ::PACIFIC BIOSCIENCES ANNOUNCES FOURTH QUARTER AND ANNUAL 2017 FINANCIAL RESULTS.Q4 REVENUE $24.9 MILLION VERSUS $25.7 MILLION.QTRLY DILUTED NET LOSS PER SHARE $0.18.  Full Article

Pacific Biosciences Of California reports Q3 revenue $23.5 mln
Thursday, 2 Nov 2017 04:01pm EDT 

Nov 2 (Reuters) - Pacific Biosciences Of California Inc :Pacific Biosciences Of California Inc announces third quarter 2017 financial results.Q3 revenue $23.5 million versus I/B/E/S view $28.5 million.Pacific Biosciences Of California Inc - ‍net loss for q3 of 2017 was $22.0 million, compared to $17.5 million for q3 of 2016​.Pacific Biosciences Of California Inc qtrly loss per share $‍0.19​.  Full Article

Pacific Biosciences of California files for mixed shelf of upto $150 mln
Wednesday, 2 Aug 2017 06:02pm EDT 

Aug 2 (Reuters) - Pacific Biosciences of California Inc :Pacific Biosciences of California Inc files for mixed shelf of upto $150 million - SEC filing‍​.  Full Article

Pacific Biosciences of California announces pricing of public offering of common stock
Thursday, 15 Jun 2017 08:30am EDT 

June 15 (Reuters) - Pacific Biosciences Of California Inc :Pacific Biosciences of California announces pricing of public offering of common stock.Says public offering of 15.4 million common shares priced at $3.10per share.  Full Article

Pacific Biosciences of California reports proposed public offering of common stock
Wednesday, 14 Jun 2017 04:01pm EDT 

June 14 (Reuters) - Pacific Biosciences of California Inc ::Pacific Biosciences of California, Inc. announces proposed public offering of common stock.Pacific Biosciences - co may also use a portion of net proceeds from offering to acquire or invest in complementary businesses.Pacific Biosciences - intends to use net proceeds from offering for capital expenditures and working capital.  Full Article

Pacific Biosciences Of California qtrly loss 26 cents/shr
Wednesday, 26 Apr 2017 04:00pm EDT 

April 26 (Reuters) - Pacific Biosciences Of California Inc ::Pacific Biosciences Of California, Inc. Announces first quarter 2017 financial results.Pacific Biosciences Of California Inc qtrly loss per share $0.26.Pacific Biosciences Of California Inc qtrly total revenue $24.9 million versus $19.1 million.Q1 earnings per share view $-0.23, revenue view $24.6 million -- Thomson Reuters I/B/E/S.  Full Article

Pacific Biosciences announces Q4 2016 financial results
Thursday, 2 Feb 2017 04:00pm EST 

Pacific Biosciences Of California Inc : Pacific Biosciences announces fourth quarter 2016 financial results . Q4 revenue $25.7 million versus I/B/E/S view $23.1 million . Pacific Biosciences of California Inc - Net loss for Q4 of 2016 was $19.0 million, compared to a net loss of $1.4 million for Q4 of 2015 . Qtrly basic and diluted net loss per share $ 0.21 .Q4 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S.  Full Article

Novogene to buy ten PacBio sequel systems for DNA sequencing services
Monday, 16 Jan 2017 03:00pm EST 

Pacific Biosciences Of California Inc :Novogene agrees to buy ten PacBio sequel systems for DNA sequencing services.  Full Article

BRIEF-Pacific Biosciences Of California Prices Public Offering

* PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK